Anorexia

Cannabidiol Attenuates the Appetitive Effects of Δ₉-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomized, controlled trial
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Dronabinol in severe, enduring anorexia nervosa: a randomized controlled trial
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomized, controlled trial
Endogenous cannabinoid system as a modulator of food intake
Hypothalamic POMC neurons promote cannabinoid-induced feeding
The cannabinoids: An overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis, and in neuroprotection
The role of the endocannabinoid system in eating disorders: neurochemical and behavioral preclinical evidence
Leptin, ghrelin, and endocannabinoids: Potential therapeutic targets in anorexia nervosa
The role of the endocannabinoid system in eating disorders: Neurochemical and behavioral preclinical evidence
Cancer cachexia and cannabinoids

CONTACT

845-988-HEMP

contact@fusioncbd.com

Want to learn more and try Fusion CBD for free?

Let’s grow together #fusionfam

© 2017 - 2020 Fusion Holding Group. All Rights Reserved.

Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your health care professional about potential interactions or other possible complications before using any product. The Federal Food, Drug and Cosmetic Act requires this notice.